CRISPR-Cas12b enables a highly efficient attack on HIV proviral DNA in T cell cultures-Reference-Cited by-同舟云学术

CRISPR-Cas12b enables a highly efficient attack on HIV proviral DNA in T cell cultures

Published:2023-09 Issue: Volume:165 Page:115046
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Fan Minghui^ORCID,Bao Yuanling,Berkhout Ben,Herrera-Carrillo Elena

Funder

National Institutes of Health

Amsterdam UMC Location AMC

China Scholarship Council

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference67 articles.

1. Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades;Levi;BMJ Glob. Health,2016

2. WHO Guidelines Approved by the Guidelines Review Committee. Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach: 2010 Revision. Geneva: World Health Organization. Copyright © 2010, World Health Organization.; 2010.

3. In vivo gene editing in dystrophic mouse muscle and muscle stem cells;Tabebordbar;Science,2016

4. A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition;Traxler;Nat. Med,2016

5. Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated Cas9 system to disrupt the hepatitis B virus;Zhen;Gene Ther.,2015

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRISPR technology in human diseases;MedComm;2024-07-29

2. What's in a cure: designing a broad-spectrum HIV gene therapy;Current Opinion in HIV and AIDS;2024-03-01